Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
110 studies found for:    "Dilated cardiomyopathy"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"Dilated cardiomyopathy"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Nesiritide - Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Nesiritide;   Drug: 5% Dextrose
2 Unknown † Cell Therapy In Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Stem cell
3 Completed Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care
4 Completed Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care
5 Unknown † Pathophysiology of Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention:
6 Completed Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Benazepril;   Drug: Valsartan;   Drug: Metoprolol
7 Completed Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy;   Chronic Heart Failure
Interventions: Procedure: Intramyocardial injection;   Procedure: Intracoronary injection
8 Terminated Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Drug: Rosiglitazone therapy
9 Recruiting Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
10 Completed
Has Results 		Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: CD34+ autologous stem cell transplantation;   Drug: Bone Marrow Stimulation;   Biological: SC therapy
11 Completed Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: granulocyte colony stimulating factor (GCSF);   Procedure: bone marrow mononuclear cells
12 Terminated PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
Condition: Dilated Cardiomyopathy
Interventions: Drug: perindopril;   Drug: placebo
13 Completed Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Intracoronary infusion of autologous bone marrow cells
14 Completed
Has Results 		Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Coenzyme Q10;   Drug: Placebo
15 Unknown † Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: umbilical cord mesenchymal stem cells
16 Active, not recruiting PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Procedure: Transendocardial injection;   Biological: Autologous hMSCs;   Biological: Allogeneic hMSCs
17 Active, not recruiting Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy
Condition: Ischemic Dilated Cardiomyopathy
Intervention: Other: BM-MSCs
18 Active, not recruiting An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)
Condition: Ischemic Dilated Cardiomyopathy (IDCM)
Interventions: Biological: ixmyelocel-T;   Other: Vehicle Control
19 Recruiting Clinical and Genetic Examinations of Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention:
20 Recruiting Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy (REMEDIUM)
Conditions: Dilated Cardiomyopathy;   Heart Failure
Intervention: Biological: Stem cell therapy
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years